MarketInOut Stock Screener Log In | Sign Up
 

Cerus Corp

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Cerus Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization474.59 mln
Float191 mln
Earnings Date11/02/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.55
Likely reliable

Relative Strength

76 / 100
Strongly outperforming

Debt / Equity

1.10
Elevated leverage

Pre-Tax Margin

-3%
Barely loss-making

ROE

-10.64
Negative

Business Description

Cerus Corporation is a California-based medical company dedicated to making blood transfusions safer. Its core product, the INTERCEPT Blood System, uses proprietary technology to eliminate harmful pathogens from donated blood components such as platelets, plasma, and red blood cells before they reach patients. The company also produces a specialized treatment for bleeding disorders related to fibrinogen deficiency, along with an LED device used in blood processing. Cerus sells its products through direct sales teams and distribution partners across the United States, Europe, the Middle East, Latin America, and beyond.

Key Fundamentals

EPS-0.03
ROE-10.64
RPS1.14
ROIC-26.04
ROA-3.15
Interest Cover-0.21
EBITDA, mln3.62
EV / EBITDA138
EV / EBIT407
Revenue, mln222
EV / Revenue2.25

Quote Details

Last 2.33
Change 0.02 (0.87%)
Open 2.31
Volume 1,912,318
Turnover 4,455,701
Average Volume 1,824,939

Financial Ratios

Pre-Tax Profit Margin-3
Leverage Ratio2.93
Current Ratio1.83
Price / Book6.80
Price / Tangible Book7.00
Price / Cash Flow195
Debt / Equity1.10
Price / Sales2.09

Financial Strength

Altman Z-Score-3.67
Piotroski F-Score 5 / 9
Beneish M-Score-2.55
Short Ratio10.54
Short % of Float8.98

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.88% 91 / 100   
1 Month -10.73% 28 / 100   
2 Months -26.03% 19 / 100   
6 Months 17.68% 88 / 100   
1 Year 55.33% 93 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog